GlaxoSmithKline: Hepatitis trials

The registry lists 17 Hepatitis studies with GlaxoSmithKline as lead sponsor. 0 are open to participants now and 5 have results posted.

Phase 1 6Phase 2 1Phase 3 4Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• A Study to Evaluate the Relative Bioavailability of Subcutaneous Bepirovirsen When Delivered From a Vial or Prefilled Syringe Fitted With a Safety Syringe Device in Healthy Adult ParticipantsCompletedNCT06058390Phase 1Results posted
• Twinrix Pregnancy RegistryCompletedNCT03619590Results posted
• Safety, Tolerability, Pharmacokinetics and Antiviral Activity of IONIS-HBVRx in Treatment-Naïve Patients With Chronic HBV InfectionCompletedNCT02981602Phase 2Results posted
• This Study Will Evaluate the Persistence of Hepatitis A Antibodies, 8 Years and 10 Years Later, in Children Who Had Received Havrix at Selected Health Centres of PanamaCompletedNCT02712359Not applicableResults posted
• Safety and Immunogenicity of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Hepatitis B VaccineCompletedNCT00657657Phase 4Results posted
• Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 2)CompletedNCT05630820Phase 3
• Study of Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B (B-Well 1)CompletedNCT05630807Phase 3
• Study to Evaluate the Pharmacokinetics of an Oral Contraceptive Containing Levonorgestrel and Ethinyl Estradiol When Co-administered With GSK1265744 in Healthy Adult Female SubjectsCompletedNCT02159131Phase 1
• Study to Assess Seroprevalence of Hepatitis A, Hepatitis B and Bordetella Pertussis in MexicoCompletedNCT02112890
• Relative Bioavailability Study of GSK1265744 FormulationsCompletedNCT01648257Phase 1
• Pharmacokinetic (PK) Profiles of Tenofovir Disoproxil Fumarate (TDF) 300 mg in Healthy Chinese SubjectsCompletedNCT01480622Phase 1
• A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult SubjectsCompletedNCT01467531Phase 1
• Methadone-Dolutegravir (DTG - GSK1349572) Drug Interaction Study.CompletedNCT01467518Phase 1
• Analysis of Trends Over Time of Hepatitis Related Incidence in PanamaCompletedNCT01159951
• Surveillance Study to Determine the Trends in Acute Hepatitis A Among Panamanian ChildrenCompletedNCT01159925
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3CompletedNCT00411385Phase 3
• Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive PatientsCompletedNCT00402428Phase 3